Sagar Lonial

Sagar Lonial

UNVERIFIED PROFILE

Are you Sagar Lonial?   Register this Author

Register author
Sagar Lonial

Sagar Lonial

Publications by authors named "Sagar Lonial"

Are you Sagar Lonial?   Register this Author

100Publications

3579Reads

46Profile Views

Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.

J Clin Invest 2019 Oct;129(10):4110-4123

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory, Emory University School of Medicine, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI125963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763259PMC
October 2019

γ-6-Phosphogluconolactone, a Byproduct of the Oxidative Pentose Phosphate Pathway, Contributes to AMPK Activation through Inhibition of PP2A.

Mol Cell 2019 Oct 2. Epub 2019 Oct 2.

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2019.09.007DOI Listing
October 2019

Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients.

Cancer 2019 Sep 15;125(17):2991-3000. Epub 2019 May 15.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32178DOI Listing
September 2019

SOHO State of the Art Updates and Next Questions: T-Cell-Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor-Modified T Cells and Bispecific T-Cell-Engaging Agents.

Clin Lymphoma Myeloma Leuk 2019 Sep 7;19(9):537-544. Epub 2019 Aug 7.

Tisch Cancer Institute, Icahn School of Medicine at Mt Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650193125
Publisher Site
http://dx.doi.org/10.1016/j.clml.2019.08.002DOI Listing
September 2019

Is there still a role for stem cell transplantation in multiple myeloma?

Cancer 2019 Aug 15;125(15):2534-2543. Epub 2019 Apr 15.

Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32060
Publisher Site
http://dx.doi.org/10.1002/cncr.32060DOI Listing
August 2019

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.

N Engl J Med 2019 08;381(8):727-738

From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1903455
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1903455DOI Listing
August 2019

Daratumumab in multiple myeloma.

Cancer 2019 Jul 5;125(14):2364-2382. Epub 2019 Apr 5.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32065DOI Listing
July 2019

Registering a CD38 antibody upfront for multiple myeloma.

Lancet 2019 07 3;394(10192):3-4. Epub 2019 Jun 3.

Winship Cancer Institute of Emory University, Atlanta, GA 30307, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31250-4DOI Listing
July 2019

Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient.

Clin Lymphoma Myeloma Leuk 2019 Jun 20;19(6):332-344. Epub 2019 Feb 20.

Winship Cancer Institute of Emory University, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.02.004DOI Listing
June 2019

Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma.

Leukemia 2019 05 24;33(5):1291-1296. Epub 2019 Jan 24.

Department of Hematology and Medical Oncology, Emory University School of Medicine and the Winship Cancer Institute of Emory University, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0374-8DOI Listing
May 2019

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.

Nat Commun 2019 04 23;10(1):1911. Epub 2019 Apr 23.

Department of Hematology and Medical Oncology, Emory University School of Medicine, 1365 Clifton Rd. NE, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-09555-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478743PMC
April 2019

Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.

Cancer 2019 02 17;125(3):416-423. Epub 2018 Oct 17.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31718
Publisher Site
http://dx.doi.org/10.1002/cncr.31718DOI Listing
February 2019

Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple Myeloma.

Cancer J 2019 Jan/Feb;25(1):19-31

From the Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000354DOI Listing
January 2019

Daratumumab and its use in the treatment of relapsed and/or refractory multiple myeloma.

Future Oncol 2018 Dec 23;14(30):3111-3121. Epub 2018 Aug 23.

Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0275DOI Listing
December 2018

Ixazomib for the treatment of multiple myeloma.

Expert Opin Pharmacother 2018 Dec 13;19(17):1949-1968. Epub 2018 Nov 13.

g Hematology & Medical Oncology , Winship Cancer Institute, Emory University , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14656566.2018.1
Publisher Site
http://dx.doi.org/10.1080/14656566.2018.1528229DOI Listing
December 2018

Response to therapeutic monoclonal antibodies for multiple myeloma in African Americans versus whites.

Cancer 2018 11 10;124(22):4358-4365. Epub 2018 Oct 10.

Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31746
Publisher Site
http://dx.doi.org/10.1002/cncr.31746DOI Listing
November 2018

Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacy.

Cancer Lett 2018 10 29;435:44-54. Epub 2018 Jul 29.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835183049
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2018.07.033DOI Listing
October 2018

Myocarditis With Radiotherapy and Immunotherapy in Multiple Myeloma.

J Oncol Pract 2018 09 13;14(9):561-564. Epub 2018 Jul 13.

Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00208DOI Listing
September 2018

Current developments in immunotherapy in the treatment of multiple myeloma.

Cancer 2018 05 6;124(10):2075-2085. Epub 2018 Feb 6.

Department of Hematology, Oncology, and Stem Cell Transplantation, Department of Medicine I, University Medical Center Freiburg, Freiburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31243DOI Listing
May 2018

CD86 regulates myeloma cell survival.

Blood Adv 2017 Nov 16;1(25):2307-2319. Epub 2017 Nov 16.

Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017011601DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729629PMC
November 2017

TG02 inhibits proteasome inhibitor-induced HSF1 serine 326 phosphorylation and heat shock response in multiple myeloma.

Blood Adv 2017 Sep 26;1(21):1848-1853. Epub 2017 Sep 26.

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University and the Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017006122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728095PMC
September 2017

High-risk Multiple Myeloma: Definition and Management.

Clin Lymphoma Myeloma Leuk 2017 07;17S:S80-S87

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.02.018DOI Listing
July 2017

Treatment of MM: Upcoming Novel Therapies.

Authors:
Sagar Lonial

Cancer Treat Res 2016 ;169:195-205

Department of Hematology and Medical Oncology, Emory University School of Medicine, 1365 Clifton Rd, Building C, Room 4004, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/978-3-319-40320
Web Search
http://dx.doi.org/10.1007/978-3-319-40320-5_11DOI Listing
June 2017

Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study.

Infect Control Hosp Epidemiol 2017 06 23;38(6):651-657. Epub 2017 Mar 23.

3Winship Cancer Institute,Emory University,Atlanta,Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/ice.2017.12DOI Listing
June 2017

Academic, Foundation, and Industry Collaboration in Finding New Therapies.

N Engl J Med 2017 May;376(18):1762-1769

From the Department Pediatrics, University of Washington School of Medicine (B.W.R.), the Center for Clinical and Translational Research, Seattle Children's Research Institute (B.W.R.), the Immune Tolerance Network (G.T.N.), and the Benaroya Research Institute (G.T.N.) - all in Seattle; and the Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University School of Medicine, Atlanta (S.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMra1612575DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912685PMC
May 2017

Deacetylase inhibitors as a novel modality in the treatment of multiple myeloma.

Pharmacol Res 2017 03 21;117:185-191. Epub 2016 Nov 21.

Clínica Universidad de Navarra, Universidad de Navarra, CIMA, IDISNA, Av. de Pio XII, 36, 31008 Pamplona, Navarra, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2016.11.020DOI Listing
March 2017

MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma.

Nucleic Acids Res 2017 03;45(5):2396-2407

Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkw1184DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389568PMC
March 2017

Deacetylase inhibitors: an advance in myeloma therapy?

Expert Rev Hematol 2017 Mar 1;10(3):229-237. Epub 2017 Feb 1.

a Department of Hematologic Malignancies , Dana-Farber Cancer Institute , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1280388DOI Listing
March 2017

Safety of proteasome inhibitors for treatment of multiple myeloma.

Expert Opin Drug Saf 2017 Feb 28;16(2):167-183. Epub 2016 Nov 28.

a Department of Hematology and Medical Oncology , Winship Cancer Institute of Emory University , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1259310DOI Listing
February 2017

New Targets and New Agents in High-Risk Multiple Myeloma.

Am Soc Clin Oncol Educ Book 2016 ;35:e431-41

From the Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159516DOI Listing
January 2017

Insights Into the Appropriate Use of New Antimyeloma Therapies.

Oncology (Williston Park) 2017 01;31(1):64, 66

View Article

Download full-text PDF

Source
January 2017

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Authors:
Kristin A Rand Chi Song Eric Dean Daniel J Serie Karen Curtin Xin Sheng Donglei Hu Carol Ann Huff Leon Bernal-Mizrachi Michael H Tomasson Sikander Ailawadhi Seema Singhal Karen Pawlish Edward S Peters Cathryn H Bock Alex Stram David J Van Den Berg Christopher K Edlund David V Conti Todd Zimmerman Amie E Hwang Scott Huntsman John Graff Ajay Nooka Yinfei Kong Silvana L Pregja Sonja I Berndt William J Blot John Carpten Graham Casey Lisa Chu W Ryan Diver Victoria L Stevens Michael R Lieber Phyllis J Goodman Anselm J M Hennis Ann W Hsing Jayesh Mehta Rick A Kittles Suzanne Kolb Eric A Klein Cristina Leske Adam B Murphy Barbara Nemesure Christine Neslund-Dudas Sara S Strom Ravi Vij Benjamin A Rybicki Janet L Stanford Lisa B Signorello John S Witte Christine B Ambrosone Parveen Bhatti Esther M John Leslie Bernstein Wei Zheng Andrew F Olshan Jennifer J Hu Regina G Ziegler Sarah J Nyante Elisa V Bandera Brenda M Birmann Sue A Ingles Michael F Press Djordje Atanackovic Martha J Glenn Lisa A Cannon-Albright Brandt Jones Guido Tricot Thomas G Martin Shaji K Kumar Jeffrey L Wolf Sandra L Deming Halverson Nathaniel Rothman Angela R Brooks-Wilson S Vincent Rajkumar Laurence N Kolonel Stephen J Chanock Susan L Slager Richard K Severson Nalini Janakiraman Howard R Terebelo Elizabeth E Brown Anneclaire J De Roos Ann F Mohrbacher Graham A Colditz Graham G Giles John J Spinelli Brian C Chiu Nikhil C Munshi Kenneth C Anderson Joan Levy Jeffrey A Zonder Robert Z Orlowski Sagar Lonial Nicola J Camp Celine M Vachon Elad Ziv Daniel O Stram Dennis J Hazelett Christopher A Haiman Wendy Cozen

Cancer Epidemiol Biomarkers Prev 2016 12 1;25(12):1609-1618. Epub 2016 Sep 1.

Keck School of Medicine of USC and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-1193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524541PMC
December 2016

New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma.

Clin Cancer Res 2016 Dec 19;22(24):5959-5965. Epub 2016 Oct 19.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0184DOI Listing
December 2016

Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth.

Mol Cell 2016 12 17;64(5):859-874. Epub 2016 Nov 17.

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2016.10.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135630PMC
December 2016

How to Integrate Elotuzumab and Daratumumab Into Therapy for Multiple Myeloma.

J Clin Oncol 2016 12 31;34(36):4421-4430. Epub 2016 Oct 31.

Craig C. Hofmeister, Ohio State University, Columbus, OH; and Sagar Lonial, Winship Cancer Institute of Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.5908DOI Listing
December 2016

Monoclonal Antibodies for the Treatment of Myeloma: Targeting SLAMF7 and CD38.

Authors:
Sagar Lonial

Cancer J 2016 Jan-Feb;22(1):3-6

From the Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000172DOI Listing
November 2016

HLA polymorphism and risk of multiple myeloma.

Leukemia 2016 11 27;30(11):2260-2264. Epub 2016 Jul 27.

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/leu.2016.199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134914PMC
November 2016

Integration of Novel Agents into the Care of Patients with Multiple Myeloma.

Clin Cancer Res 2016 Nov 14;22(22):5443-5452. Epub 2016 Nov 14.

Department of Hematology & Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-16-0861DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705234PMC
November 2016

Update on elotuzumab, a novel anti-SLAMF7 monoclonal antibody for the treatment of multiple myeloma.

Expert Opin Biol Ther 2016 10 17;16(10):1291-301. Epub 2016 Aug 17.

d Jerome Lipper Multiple Myeloma Center , Dana-Farber Cancer Institute , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2016.1221920DOI Listing
October 2016

Bortezomib-induced heat shock response protects multiple myeloma cells and is activated by heat shock factor 1 serine 326 phosphorylation.

Oncotarget 2016 Sep;7(37):59727-59741

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University and the Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.10847DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312344PMC
September 2016

Is Maintenance Therapy for Everyone?

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S139-44

Division of Bone Marrow Transplant, Winship Cancer Institute, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.02.011DOI Listing
August 2016

Death by a thousand cuts: the slow demise of chemotherapy.

Cancer 2016 07 18;122(13):1971-3. Epub 2016 May 18.

Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30024DOI Listing
July 2016

Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma.

Cancer Biol Ther 2016 07;17(7):769-77

b Department of Hematology and Medical Oncology , Winship Cancer Institute of Emory University , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2016.1192086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970534PMC
July 2016

Novel Combination Treatments in Multiple Myeloma.

Oncology (Williston Park) 2016 May;30(5):451-65

View Article

Download full-text PDF

Source
May 2016

Gene integrated set profile analysis: a context-based approach for inferring biological endpoints.

Nucleic Acids Res 2016 Apr 29;44(7):e69. Epub 2016 Jan 29.

Winship Cancer Institute, Emory University, Atlanta, GA 30333, USA Department of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkv1503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838358PMC
April 2016

Myeloma Is Not a Single Disease.

J Oncol Pract 2016 Apr;12(4):287-92

Emory University School of Medicine, Atlanta, GA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2016.010926
Publisher Site
http://dx.doi.org/10.1200/JOP.2016.010926DOI Listing
April 2016

Emerging treatments in Castleman disease - a critical appraisal of siltuximab.

Biologics 2016 25;10:9-15. Epub 2016 Jan 25.

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BTT.S60523DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734738PMC
February 2016

Monoclonal antibodies in multiple myeloma: data from the 2015 ASH meeting.

Authors:
Sagar Lonial

Clin Adv Hematol Oncol 2016 Feb;14(2):82-4

Winship Cancer Institute of Emory University, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
February 2016